[Pediatrics. Fecal calprotectin in children: use and interpretation]

J Ezri1, A Nydegger

  • 1Unité de gastroentérologie et nutrition pédiatriques, Département médico-chirurgical de pédiatrie, CHUV, 1011 Lausanne.

Revue Medicale Suisse
|February 12, 2011
PubMed

Insights

Fecal calprotectin is a non-invasive biomarker for gastro-intestinal inflammation. Elevated levels can help differentiate functional disorders from inflammatory bowel disease (IBD) and monitor IBD treatment.

Area of Science:

  • Gastroenterology
  • Biomarker Discovery
  • Clinical Diagnostics

Context:

  • Fecal calprotectin is a protein released by neutrophils, serving as a key indicator of gastro-intestinal inflammation.
  • Normal fecal calprotectin levels differ significantly across age groups, with higher thresholds in infants and children compared to adults.
  • Recurrent abdominal pain evaluation benefits from fecal calprotectin testing to differentiate functional disorders from inflammatory conditions.

Purpose:

  • To highlight fecal calprotectin as a reliable, non-invasive biomarker for gastro-intestinal inflammation.
  • To establish age-specific normal values for fecal calprotectin.
  • To assess the utility of fecal calprotectin in distinguishing functional gastro-intestinal disorders from inflammatory bowel disease (IBD).

Summary:

  • Fecal calprotectin is a neutrophil-derived protein that reliably indicates gastro-intestinal inflammation.
  • Age-adjusted cut-off values are crucial for interpreting fecal calprotectin results.
  • This biomarker aids in differentiating functional abdominal pain from IBD and monitoring therapeutic responses in IBD patients.

Impact:

  • Facilitates non-invasive diagnosis and management of gastro-intestinal inflammatory conditions.
  • Improves diagnostic accuracy in patients presenting with recurrent abdominal pain.
  • Provides a valuable tool for monitoring treatment efficacy in inflammatory bowel disease.